Official websites use. Share sensitive information only on official, secure websites. This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. To date, there is little evidence to justify stopping screening at 74 years of age. The tests performed in a circumstance of delayed response to a solicitation DRS from the local cancer screening managing center Managing-Center were distinguished from the tests non-solicited by the Managing-Center, performed after a recommendation by a General Practitioner GP or other provider ordered RGP.
The outcomes of these tests were described according to the circumstances of test completion. Of screening-tests were performed at ages: 75 The proportion of the tests that could not be analyzed and not restarted was For these unanalyzed tests, the reason was age-related in Reported colonoscopy completion rate was For those people with reported colonoscopy, no complication was listed.
Keywords: Colorectal cancer, Fecal screening test, Participation rate, Colonoscopy completion rate, Elderly. Core tip: Reported colonoscopy completion rate was In addition to its high incidence and high mortality around new cases and deaths per year , colorectal cancer CRC meets all the conditions to be screened in France[ 1 - 3 ]. Screening every two years, allows to obtain a reduction in CRC mortality in tested population[ 2 , 3 ].
Following the recommendations, the screening of the CRC started in Germany in [ 5 ], was progressively implemented between and in other European countries, through CRC screening pilot programs, notably in England[ 6 ], in Italy[ 7 ] in Holland[ 8 , 9 ] and in France[ 10 ].
To date, most of the CRCSP policies target a medium risk population of CRC, defined on the age criterion with considerable variability from one program to another[ 11 ]. Since the effectiveness of screening depends on its application in an appropriate setting and at an appropriate frequency[ 12 ], most European programs, observe an interval of 2 years between two screenings campaign. The test was offered to people all gender aged between 40 and 60 in Bulgaria, between 50 and 74 in France, England and Belgium; between 50 and 70 in Italy, between 55 and 75 in Holland[ 13 ].
